- Home
- ONL vs MIST Comparison
ONL vs MIST Comparison
Compare ONL & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ONL | MIST |
|---|---|---|
| Founded | 2021 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.4M | 136.9M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ONL | MIST |
|---|---|---|
| Price | $2.90 | $1.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $3.00 | ★ $8.00 |
| AVG Volume (30 Days) | 265.5K | ★ 1.6M |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | ★ 2.83% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $147,647,000.00 | N/A |
| Revenue This Year | $4.10 | $2,915.14 |
| Revenue Next Year | $3.10 | N/A |
| P/E Ratio | $15.21 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.92 | $1.00 |
| 52 Week High | $3.05 | $3.06 |
Technical Indicators
Market Signals| Indicator | ONL | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 58.59 | 37.03 |
| Support Level | $2.81 | $1.01 |
| Resistance Level | $3.00 | $1.42 |
| Average True Range (ATR) | 0.10 | 0.07 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 61.46 | 0.33 |
Price Performance
Historical ComparisonAbout ONL Orion Office REIT Inc.
Orion Properties Inc is an internally managed real estate investment trust engaged in the ownership, acquisition, and management of a diversified portfolio of office properties located in high-quality suburban markets across the United States and leased mainly on a single-tenant net lease basis to creditworthy tenants. Its portfolio is comprised of traditional office properties, as well as governmental, medical office, flex/laboratory, and R&D and flex/industrial properties. The company is focused on shifting its portfolio concentration over time away from traditional office properties, towards more dedicated use assets with specialized uses that include an office component. It operates in one business segment: commercial real estate.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.